BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6777839)

  • 21. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
    Grossie VB; Nishioka K
    Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of antitumor activity of alpha-difluoromethyl ornithine by the immunomodulating peptide tuftsin.
    Sunkara PS; Prakash NJ; Nishioka K
    Ann N Y Acad Sci; 1983; 419():268-72. PubMed ID: 6424536
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.
    Gupta S; Ahmad N; Mohan RR; Husain MM; Mukhtar H
    Cancer Res; 1999 May; 59(9):2115-20. PubMed ID: 10232597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
    Aizencang G; Harari P; Buldain G; Guerra L; Pickart M; Hernandez P; Frydman B
    Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):615-25. PubMed ID: 9678897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of alpha-difluoromethyl-ornithine on tumor growth, acute phase reactants, beta-2-microglobulin and hydroxyproline in kidney and bladder carcinomas.
    Dunzendorfer U
    Urol Int; 1981; 36(2):128-36. PubMed ID: 6169180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine decarboxylase lability in 2 transplantable highly deviated rat hepatomas.
    Zuretti MF; Gravela E
    Cancer Lett; 1987 Jul; 36(1):35-43. PubMed ID: 3581055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cure of hepatoma in rat with the nitrosourea carmustine (BCNU).
    Roos G; Stenram U
    Anticancer Res; 1994; 14(5A):2059-60. PubMed ID: 7847850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
    Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
    J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of ornithine decarboxylase antizyme (ODC-Az) level in the 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.
    Tsuji T; Todd R; Meyer C; McBride J; Liao PH; Huang MF; Chou MY; Donoff RB; Wong DT
    Oncogene; 1998 Jul; 16(26):3379-85. PubMed ID: 9692545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate.
    Tørring N; Vinter-Jensen L; Pedersen SB; Sørensen FB; Flyvbjerg A; Nexø E
    J Urol; 1997 Jul; 158(1):222-7. PubMed ID: 9186364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth inhibition of a prostate tumor by alpha-difluoromethylornithine and by cyclophosphamide.
    Heston WD; Kadmon D; Fair WR
    Cancer Lett; 1982; 16(1):71-79. PubMed ID: 6811130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of polyamines in HeLa cell proliferation.
    Herbst EJ; Elliot QD
    Med Biol; 1981 Dec; 59(5-6):410-6. PubMed ID: 6803079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
    Oredsson SM; Deen DF; Marton LJ
    Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics and phases of changes in the primary focus of Morris hepatoma under local application of cytokine hrecTNF-alpha.
    Terlikowski S; Nowak HF; Lotocki W
    Neoplasma; 1996; 43(2):125-32. PubMed ID: 8843975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of flavone acetic acid on the growth of a rat tumour.
    Bowler K; Pearson JA
    Anticancer Res; 1992; 12(4):1275-9. PubMed ID: 1503421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies on the ultrastructure of the rat lungs after intratumor treatment of Morris hepatoma with rhTNF-alpha and its muteins.
    Terlikowski S; Sulkowski S; Sulkowska M; Nowak HF
    J Submicrosc Cytol Pathol; 1999 Apr; 31(2):265-72. PubMed ID: 10457612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Hung DT; Deen DF; Seidenfeld J; Marton LJ
    Cancer Res; 1981 Jul; 41(7):2783-5. PubMed ID: 6788362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppression with a combination of alpha-difluoromethyl ornithine and interferon.
    Sunkara PS; Prakash NJ; Mayer GD; Sjoerdsma A
    Science; 1983 Feb; 219(4586):851-3. PubMed ID: 6186025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.